Surya Pharmaceutical Financials
NSE: SURYAPHARM | BSE: 532516
₹0.16
As on 14-Sep-2015IST
Market cap
₹3 Cr
Revenue (TTM)
₹3 Cr
P/E Ratio
0
P/B Ratio
-0
Div. Yield
0 %
Income Statement (₹ Cr) |
TTM | Mar-13 | Mar-12 | Mar-11 | Mar-10 | Mar-09 | Mar-08 | Mar-07 | Mar-06 | Mar-05 | Mar-04 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
2.60
|
60.33
|
1,622.95
|
1,600.42
|
1,134.14
|
722.92
|
|||||
|
Total Income
|
--
|
61.18
|
1,627.58
|
1,603.89
|
1,144.63
|
727.68
|
|||||
|
Total Expenditure
|
49.09
|
232.59
|
1,807.65
|
1,337.87
|
971.25
|
606.38
|
|||||
|
EBITDA
|
-46.48
|
-172.26
|
-184.70
|
262.54
|
162.88
|
116.54
|
|||||
|
Depreciation
|
--
|
62.47
|
34.62
|
26.55
|
20.55
|
16.05
|
|||||
|
EBIT
|
-77.72
|
-234.73
|
-219.32
|
236.00
|
142.33
|
100.50
|
|||||
|
Interest
|
107.91
|
206.90
|
178.54
|
107.75
|
62.36
|
41.16
|
|||||
|
Other Income
|
--
|
0.85
|
4.63
|
3.47
|
10.50
|
4.76
|
|||||
|
Exceptional Items
|
--
|
-17.93
|
--
|
--
|
--
|
--
|
|||||
|
Profit before Tax
|
-185.18
|
-458.71
|
-393.22
|
131.72
|
90.46
|
64.10
|
|||||
|
Provision for Tax
|
--
|
-156.90
|
-120.07
|
31.56
|
14.40
|
7.97
|
|||||
|
Profit after Tax
|
258.68
|
-301.81
|
-273.16
|
100.16
|
76.06
|
56.13
|
Liabilities (₹ Cr) |
TTM | Mar-13 | Mar-12 | Mar-11 | Mar-10 | Mar-09 | Mar-08 | Mar-07 | Mar-06 | Mar-05 | Mar-04 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
-776.29
|
-54.33
|
247.48
|
519.95
|
303.19
|
230.11
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Non-Current Liabilities
|
186.62
|
35.43
|
141.69
|
331.28
|
721.33
|
514.91
|
|||||
|
Current Liabilities
|
2,132.86
|
1,790.83
|
1,637.12
|
1,314.60
|
361.92
|
203.83
|
|||||
|
Total Liabilities
|
1,543.19
|
2,017.48
|
2,127.66
|
2,165.83
|
1,386.44
|
948.85
|
Assets (₹ Cr) |
TTM | Mar-13 | Mar-12 | Mar-11 | Mar-10 | Mar-09 | Mar-08 | Mar-07 | Mar-06 | Mar-05 | Mar-04 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
1,413.66
|
803.02
|
854.99
|
657.95
|
433.48
|
301.03
|
|||||
|
Current Assets
|
128.16
|
968.90
|
1,171.30
|
1,507.87
|
950.90
|
646.98
|
|||||
|
Total Assets
|
1,543.20
|
2,017.48
|
2,127.66
|
2,165.83
|
1,386.44
|
948.85
|
|||||
|
Total Debt*
|
--
|
2,009.07
|
1,754.17
|
1,441.22
|
708.11
|
500.73
|
|||||
|
Net Current Assets
|
-2,004.70
|
-821.93
|
-465.82
|
193.27
|
588.98
|
443.15
|
|||||
|
Contingent Liabilities
|
--
|
266.81
|
175.77
|
184.45
|
108.65
|
57.71
|
Cashflow (₹ Cr) |
TTM | Mar-13 | Mar-12 | Mar-11 | Mar-10 | Mar-09 | Mar-08 | Mar-07 | Mar-06 | Mar-05 | Mar-04 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
165.55
|
385.56
|
68.93
|
165.31
|
-8.10
|
|||||
|
Cash Flow from Investing Activities
|
--
|
-7.90
|
-149.98
|
-245.00
|
-144.32
|
-120.66
|
|||||
|
Cash from Financing Activities
|
--
|
-160.30
|
-241.17
|
173.64
|
-11.32
|
103.26
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
-2.65
|
-5.60
|
-2.43
|
9.68
|
-25.49
|
Financials Ratios |
TTM | Mar-13 | Mar-12 | Mar-11 | Mar-10 | Mar-09 | Mar-08 | Mar-07 | Mar-06 | Mar-05 | Mar-04 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
12.76
|
-14.89
|
-13.47
|
5.20
|
5.26
|
3.88
|
|||||
|
Cash EPS (₹)
|
--
|
-11.80
|
-11.76
|
6.57
|
6.68
|
4.99
|
|||||
|
Adjusted Book Value (₹)
|
--
|
-2.68
|
12.21
|
26.63
|
20.81
|
15.85
|
|||||
|
Dividend per Share (₹)
|
--
|
--
|
--
|
0.15
|
0.15
|
0.12
|
|||||
|
Cash Flow per Share (₹)
|
--
|
8.17
|
19.02
|
3.58
|
114.26
|
-5.60
|
|||||
|
Free Cash Flow per Share (₹)
|
--
|
3.82
|
9.47
|
-14.50
|
-30.91
|
-111.92
|
Profitability Ratios |
TTM | Mar-13 | Mar-12 | Mar-11 | Mar-10 | Mar-09 | Mar-08 | Mar-07 | Mar-06 | Mar-05 | Mar-04 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
-12.73
|
-10.84
|
16.12
|
17.57
|
17.17
|
|||||
|
ROE (%)
|
--
|
-312.51
|
-71.80
|
24.59
|
28.68
|
27.57
|
|||||
|
ROA (%)
|
14.53
|
-15.89
|
-13.03
|
5.64
|
6.51
|
7.15
|
|||||
|
EBIT Margin (%)
|
-2,984.56
|
-389.07
|
-13.51
|
14.75
|
12.55
|
13.90
|
|||||
|
Net Margin (%)
|
9,933.76
|
-493.33
|
-16.78
|
6.24
|
6.64
|
7.71
|
|||||
|
Cash Profit Margin (%)
|
--
|
-370.38
|
-14.46
|
7.76
|
8.35
|
9.60
|
Growth Ratios |
TTM | Mar-13 | Mar-12 | Mar-11 | Mar-10 | Mar-09 | Mar-08 | Mar-07 | Mar-06 | Mar-05 | Mar-04 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-82.33
|
-96.28
|
1.41
|
41.11
|
56.88
|
48.59
|
|||||
|
EBIT Growth (%)
|
90.42
|
-7.03
|
-192.93
|
65.81
|
41.62
|
30.14
|
|||||
|
Net Profit Growth (%)
|
120.97
|
-10.49
|
-372.72
|
31.68
|
35.51
|
34.56
|
|||||
|
EPS Growth (%)
|
120.97
|
-10.49
|
-359.27
|
-1.16
|
35.51
|
34.55
|
|||||
|
Book Value Growth (%)
|
--
|
-121.95
|
-51.79
|
70.49
|
31.34
|
28.89
|
Valuation Ratios |
TTM | Mar-13 | Mar-12 | Mar-11 | Mar-10 | Mar-09 | Mar-08 | Mar-07 | Mar-06 | Mar-05 | Mar-04 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
0.01
|
--
|
--
|
4.71
|
0.34
|
0.14
|
|||||
|
Price / Book Value
|
0.00
|
-0.43
|
0.89
|
0.92
|
0.85
|
0.34
|
|||||
|
Dividend Yield (%)
|
--
|
--
|
--
|
0.61
|
0.85
|
2.25
|
|||||
|
EV/EBITDA
|
-40.86
|
-11.81
|
-10.90
|
7.13
|
5.46
|
4.70
|
|||||
|
Close Price (₹)
|
0.21
|
1.20
|
10.80
|
24.05
|
17.65
|
5.36
|
|||||
|
High Price (₹)
|
1.93
|
12.20
|
29.00
|
35.68
|
18.90
|
12.98
|
|||||
|
Low Price (₹)
|
0.21
|
1.15
|
9.40
|
16.19
|
5.31
|
4.66
|
|||||
|
Market Cap (₹ Cr)
|
3.24
|
23.32
|
219.38
|
472.24
|
256.16
|
77.26
|
Solvency Ratios |
TTM | Mar-13 | Mar-12 | Mar-11 | Mar-10 | Mar-09 | Mar-08 | Mar-07 | Mar-06 | Mar-05 | Mar-04 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
-0.21
|
-36.98
|
7.09
|
2.81
|
2.35
|
2.18
|
|||||
|
Short term debt to equity ratio
|
-2.39
|
-29.86
|
5.80
|
2.13
|
--
|
--
|
|||||
|
Current Ratio
|
0.06
|
0.54
|
0.72
|
1.15
|
2.63
|
3.17
|
|||||
|
Quick Ratio
|
0.06
|
0.19
|
0.22
|
0.36
|
0.81
|
1.34
|
|||||
|
Interest Coverage
|
-0.72
|
-1.22
|
-1.20
|
2.22
|
2.45
|
2.56
|
Operating Efficiency Ratios |
TTM | Mar-13 | Mar-12 | Mar-11 | Mar-10 | Mar-09 | Mar-08 | Mar-07 | Mar-06 | Mar-05 | Mar-04 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
213.29
|
372.95
|
14.55
|
18.17
|
13.50
|
18.99
|
|||||
|
Asset Turnover
|
0.00
|
0.03
|
0.79
|
0.92
|
0.99
|
0.96
|
|||||
|
Receivable days
|
--
|
1,302.53
|
58.29
|
49.60
|
45.78
|
53.56
|
|||||
|
Inventory Days
|
--
|
4,068.63
|
204.93
|
189.72
|
162.46
|
148.15
|
|||||
|
Payable days
|
--
|
75.22
|
12.73
|
49.24
|
90.49
|
87.75
|
|||||
|
Cash Conversion Cycle
|
--
|
5,295.94
|
250.49
|
190.09
|
117.76
|
113.96
|